Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. - Wikidata - awgldk - TriplyDB

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.

http://www.wikidata.org/entity/Q36364479

about

Effect of bisphenol A on murine immune function: modulation of interferon-gamma, IgG2a, and disease symptoms in NZB X NZW F1 mice Immunological aspects in chronic lymphocytic leukemia (CLL) development Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosus CD40 gene silencing reduces the progression of experimental lupus nephritis modulating local milieu and systemic mechanisms IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells Development of murine lupus involves the combined genetic contribution of the SLAM and FcgammaR intervals within the Nba2 autoimmune susceptibility locus.Treatment of lupus-induced thrombocytopenia with recombinant human interleukin-11.Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus.Assessing the human immune system through blood transcriptomics.Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity.Interleukin-10: an anti-inflammatory cytokine with therapeutic potential.A genomic approach to human autoimmune diseases.Tumour necrosis factor and other cytokines in murine lupus.IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus Major peptide autoepitopes for nucleosome-specific T cells of human lupus.Cytokines and systemic lupus erythematosus Human TCR-alpha beta+ CD4- CD8- T cells can derive from CD8+ T cells and display an inflammatory effector phenotype Hypomethylation of IL10 and IL13 promoters in CD4+ T cells of patients with systemic lupus erythematosus.Olf1/EBF associated zinc finger protein interfered with antinuclear antibody production in patients with systemic lupus erythematosus.Estrogen receptor signaling and its relationship to cytokines in systemic lupus erythematosus.The clinical usefulness of the measurement of cytokines.Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus.Genetic variations and interactions in anti-inflammatory cytokine pathway genes in the outcome of leprosy: a study conducted on a MassARRAY platform.Genetic studies of human lupus in families.Lupus susceptibility genes on human chromosome 1.Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling Monoclonal antibodies and other biologic therapies.New therapies in development for autoimmune diseases: their rationale for combination treatment.Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes.Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells Fas-independent T-cell apoptosis by dendritic cells controls autoimmune arthritis in MRL/lpr mice.Invariant NKT cells inhibit autoreactive B cells in a contact- and CD1d-dependent manner.Treatment of systemic lupus erythematosus with epratuzumab.Current and novel therapeutics in the treatment of systemic lupus erythematosus Pathologic patterns of interleukin 10 expression--a review.Abnormal T cell signal transduction in systemic lupus erythematosus.Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study.IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis

P2860

Q24816987-71A882B9-5492-4587-B0C4-CCC394B4C1A4 Q26865940-3A59DDE0-A5AE-49CA-B5C6-CEAF4EFC488D Q28269798-1357EC40-8793-49E8-B7C3-3D9625EE54EC Q28533954-A1132AD6-1AC7-4938-B3ED-F8B0A223FCB6 Q28590243-448D787B-2993-4134-8F45-EC5F37C2B40D Q30433488-6182D51D-4111-428A-B4D9-1CF95C0CE644 Q32045005-6736F716-0250-4A69-90F6-376096CD4D4A Q33340529-49B76D38-EE1F-4B50-BAD5-CFC7B661DD22 Q33608479-AF9EC850-F188-429C-A841-73353F537A55 Q33608533-B92D66C9-06F2-428D-8B79-C2EB9E10FCBB Q33629522-8DE89B21-C8AB-40CB-A92E-1E11B9A5E007 Q33664752-0EE47249-D22E-4AE9-A6FA-679320549BE2 Q33723684-57F8CB0A-DC93-4C60-A0A5-8C6B2BDD5231 Q33762839-E3269A5F-49B7-4560-A95E-CDBDDEEC5B91 Q33782338-4A1565D8-9ED4-4C05-BF3B-E731448270F8 Q33804141-6D154018-BEF8-4E0B-8E47-5D5A07616F41 Q33853601-B5E2D40C-210B-488E-AC4D-564995E530A2 Q33873329-BEB6BAF6-5987-4F6D-9ACD-05928CF62B7F Q33884252-F1553967-3B31-43D9-80E7-B392367B52FF Q33889455-713900EB-9921-484C-99FF-1252EED40852 Q33923396-9D334A8B-8E12-48FC-809F-83BEE107BF1D Q33960009-DC295F27-9994-4F91-ABEB-C5B7CF54756A Q33992704-1013E1D3-6417-4E17-A601-E6DE68D55989 Q34002864-9599BD3E-2404-4132-8CAB-D604CA025316 Q34019660-7D7C5654-CE3D-4636-B391-6E80EE0D49F4 Q34051970-BE7035E4-EE0B-4F90-95ED-E6F0CE90B008 Q34051976-62891889-8CCB-4B0B-A8A9-FC5CF974AE14 Q34217935-11635871-B60B-4A4B-B377-74E99A0A32D2 Q34227074-8F8EB0CF-B194-4D3B-A7AD-0916D4E950FE Q34309745-D5E28831-D9CC-414C-8506-BC0D27B6D4E6 Q34462053-6F0862EC-6A8D-427D-A266-908EC7AB4508 Q34480485-9D454B17-AB0B-4DCA-8139-CD85935E7759 Q34539976-E14A52CB-E2B5-42A9-8433-3376B072233D Q34574833-5E2D0EAF-00D0-4839-9F31-624B44CC0ED6 Q34580559-A87874DD-EE97-4E56-8705-991BF33EC347 Q34648851-52D64E56-0AEB-497C-AAB8-806A4D018670 Q34667904-7F09259E-E30F-4DB4-948B-813F0138B106 Q34736534-EEB338CF-91EC-4856-AF59-3FBC8035ADAA Q34897189-CCD11941-A19B-460B-AE90-A25E86B9A272 Q34920423-23BDF759-5B02-46FC-B309-E8AFC1D30FDD

P2860

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.

http://www.wikidata.org/entity/Q36364479

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年学术文章

@wuu

1995年学术文章

@zh-cn

1995年学术文章

@zh-hans

1995年学术文章

@zh-my

1995年学术文章

@zh-sg

1995年學術文章

@yue

1995年學術文章

@zh

1995年學術文章

@zh-hant

name

Role of interleukin 10 in the ...... systemic lupus erythematosus.

@ast

Role of interleukin 10 in the ...... systemic lupus erythematosus.

@en

type

label

Role of interleukin 10 in the ...... systemic lupus erythematosus.

@ast

Role of interleukin 10 in the ...... systemic lupus erythematosus.

@en

prefLabel

Role of interleukin 10 in the ...... systemic lupus erythematosus.

@ast

Role of interleukin 10 in the ...... systemic lupus erythematosus.

@en

P1433

Q36364479-7C431FB0-0234-4A56-A417-AF33BA3B236B

P1476

Q36364479-9522DDFE-8263-4E20-9DAC-15F77C1C5FF6

P2093

Q36364479-00531A5B-4682-4642-A9E0-6C3D19E38A2A

Q36364479-038AED05-CED8-4D1B-9C89-ABBAC1FD44F8

Q36364479-0CD17555-2363-4D98-B7E1-CD969EA438BD

Q36364479-0D29A5B0-4103-425F-AEB0-BA232D19A6A8

Q36364479-2E8BF764-EED0-42C1-9698-F761ECBDF24B

Q36364479-516927B9-4D3B-4FA8-A50D-C0FAEC8FA676

Q36364479-9BB11E4B-6F63-4711-8D28-E8602694AEA9

Q36364479-9ED49674-53D4-4ECA-BA80-E41CAD8B37B3

Q36364479-B6B72C86-A2EF-4723-8860-9B169774EB35

Q36364479-E83FEFA9-FFD2-4F0A-930D-F9A48EF2CF22

P2860

Q36364479-0CA1F05B-ADEA-4D38-8A1A-E71327E78B5C

Q36364479-6117360D-6F20-45FF-884E-7EC1C899EC82

Q36364479-620C59C7-25EB-49F1-809A-C3398523D63C

Q36364479-69C588D9-0145-49C2-AC54-C0B2370B68E3

Q36364479-743F6007-F76E-4F97-AA2F-D4A00A716832

Q36364479-76ABAE51-7F1D-40B6-8F01-8173A5475043

Q36364479-7CFF930C-C143-445A-95F7-7246C8E9AAD4

Q36364479-7EEAAECA-22FB-4400-A5FE-C070E8B8110E

Q36364479-8EE4149F-991B-4469-B60B-C4915FAD37BB

Q36364479-91692374-D4CC-41BD-A080-7E4B0B8B05FD

P304

Q36364479-22A7713C-03FD-450E-80EA-FB63691E0A0C

P31

Q36364479-73AB5E68-8A5D-4A03-AE5B-F82A9E50F229

P356

Q36364479-6D68EE3E-5332-45DE-B872-2BA037EB2A16

P407

Q36364479-CC4A1121-B069-4CE4-A113-11CD9755EA6F

P433

Q36364479-3C0EF5ED-2248-4D94-A707-6224BFC6BB28

P478

Q36364479-18BD06FC-1402-4E1B-89ED-1E387CB44C8A

P577

Q36364479-ED0A82D6-08F6-4E2B-89FB-684D355AFFC4

P5875

Q36364479-5FE9F075-F6DA-49D3-916E-EC08982C07A8

P698

Q36364479-0DEAC643-6829-4373-89FE-895A5DFAA722

P921

Q36364479-D3234F4B-5EC8-4C36-83C0-B54E8226F9D7

Q36364479-EB573ECE-5FB6-4AED-8489-C6819FB7E1CE

P932

Q36364479-80B392AE-0B60-42FF-A259-B2F9C0D32570

P356

P1433

Journal of Experimental Medicine

P1476

Role of interleukin 10 in the ...... systemic lupus erythematosus.

@en

P2093

Alarcon-Segovia D

http://www.w3.org/2001/XMLSchema#string

Alcocer-Varela J

http://www.w3.org/2001/XMLSchema#string

Brouet JC

http://www.w3.org/2001/XMLSchema#string

Emilie D

http://www.w3.org/2001/XMLSchema#string

Galanaud P

http://www.w3.org/2001/XMLSchema#string

Levy Y

http://www.w3.org/2001/XMLSchema#string

Llorente L

http://www.w3.org/2001/XMLSchema#string

Morel-Fourrier B

http://www.w3.org/2001/XMLSchema#string

Richaud-Patin Y

http://www.w3.org/2001/XMLSchema#string

Wijdenes J

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

The 1982 revised criteria for the classification of systemic lupus erythematosus

Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms.

Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein.

Delayed hypersensitivity in systemic lupus erythematosus.

A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody

Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells

Systemic autoimmune disease arises from polyclonal B cell activation.

Lymphocyte biology in lupus.

Cytokines from lymphoid organs of HIV-infected patients: production and role in the immune disequilibrium of the disease and in the development of B lymphomas.

P304

839-844

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.181.3.839

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

181

http://www.w3.org/2001/XMLSchema#string

P577

1995-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15330274

http://www.w3.org/2001/XMLSchema#string

P698

7869046

http://www.w3.org/2001/XMLSchema#string

P921

P932

2191898

http://www.w3.org/2001/XMLSchema#string